Tumor Genomics Market – Transforming Cancer Diagnostics Through Next-Generation Sequencing
The Tumor Genomics Market is being shaped by advances in molecular diagnostic technologies that help identify genetic alterations in cancer. Next-generation sequencing (NGS) enables laboratories to examine multiple genomic regions and detect selected variations that may be relevant to cancer research and clinical assessment.
Current Market Landscape
NGS-based tumor testing is used in...
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek